速览！“十四五”时期市场监管高质量发展成就

Group 1 - Since the beginning of the 14th Five-Year Plan, the number of new enterprises in China has increased by 19.999 million, with individual businesses increasing by 33.946 million [2] - During the 14th Five-Year Plan, national market regulatory authorities handled 89.028 million complaints and reports, recovering economic losses of 21.71 billion yuan for consumers [4] - The total number of national standards in China has reached over 47,000, with more than 13,000 new national standards released during the 14th Five-Year Plan [6] Group 2 - China's pharmaceutical industry ranks second globally, with approximately 30% of innovative drugs under research worldwide [8] - A total of 387 children's medicines and 147 rare disease medicines have been approved for market since the beginning of the 14th Five-Year Plan, effectively meeting the medication needs of key populations [8]